Brain + body + integrator robotics stack (KraneShares KOID thesis)
Humanoid robotics value chain: brain + body + integrator stack.
| Symbol | Action | Vol | Stop Loss | Take Profit | Size | Links |
|---|---|---|---|---|---|---|
| ADI | BUY | 36% | 38.1% below entry | 20.6% above entry | 6.4% | TVYH |
| ROK | BUY | 32% | 34.0% below entry | 18.4% above entry | 7.2% | TVYH |
| BOTZ | BUY | 26% | 27.4% below entry | 14.8% above entry | 8.9% | TVYH |
| MBLY | BUY | 65% | 40.0% below entry | 36.8% above entry | 3.6% | TVYH |
| APH | BUY | 39% | 40.0% below entry | 22.0% above entry | 6.0% | TVYH |
| RRX | BUY | 45% | 40.0% below entry | 25.8% above entry | 5.1% | TVYH |
| JBL | BUY | 40% | 40.0% below entry | 23.0% above entry | 5.7% | TVYH |
| TER | BUY | 58% | 40.0% below entry | 32.7% above entry | 4.0% | TVYH |
| ISRG | BUY | 32% | 33.6% below entry | 18.2% above entry | 7.3% | TVYH |
| NVDA | BUY | 49% | 40.0% below entry | 27.6% above entry | 4.8% | TVYH |
| TEL | BUY | 30% | 31.3% below entry | 16.9% above entry | 7.8% | TVYH |
This strategy has strong long-term performance with good consistency (93% of windows positive Sharpe). Consider allocating 5-10% of portfolio. Rebalance quarterly. Simplest passive approach: Equal-weight NVDA, ISRG, APH, ROK, ADI. These five span AI compute (NVDA), surgical precision integration (ISRG), connectivity backbone (APH), industrial automation (ROK), and analog sensing (ADI). Or buy BOTZ for managed robotics exposure. Note: MBLY (Mobileye) only IPO'd in late 2022, so it contributes only in recent windows. ABB has data issues on some providers. The strategy gracefully handles missing tickers by redistributing weight.